<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0" xml:base="http://www.fiercepharma.com" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
 <title>Melissa DelBello</title>
 <link>http://www.fiercepharma.com/tags/melissa-delbello</link>
 <description></description>
 <language>en</language>
<item>
 <title>Seroquel researcher got cash from AZ</title>
 <link>http://www.fiercepharma.com/story/seroquel-researcher-got-cash-from-az/2008-04-08?utm_medium=rss&amp;utm_source=rss&amp;cmp-id=OTC-RSS-FP0</link>
 <description>&lt;p&gt;
Sen. Charles Grassley&#039;s hall of shame: The chairman of the Senate Finance Committee, who&#039;s been trying to rally support for a bill requiring drug and device makers to disclose anything of value given to doctors, raised the case of Dr. Melissa DelBello, a psychiatrist who got hundreds of thousands of dollars in travel expenses, consulting fees, and lecture payments from AstraZeneca. DelBello also happened to be lead author of a study that concluded kids did well on AstraZeneca&#039;s antipsychotic med Seroquel.
&lt;/p&gt;
&lt;p&gt;
Here&#039;s the timeline: DelBello authored the study, published in 2002. In 2003, she got $100,000 from the drugmaker, or so she told the University of Cincinnati. In 2004, she reported $80,000. AstraZeneca&#039;s figures total $238,000.
&lt;/p&gt;
&lt;p&gt;
Grassley was pretty peeved not only about the apparent conflict of interest--which AstraZeneca denied; DelBello wasn&#039;t available for comment--but also by the fact that DelBello also got NIH funding during the same period. University of Cincinnati said it applauds Grassley&#039;s &amp;quot;looking into this very important issue.&amp;quot;
&lt;/p&gt;
&lt;p&gt;
- read the &lt;em&gt;WSJ Health Blog&lt;/em&gt; &lt;a href=&quot;http://blogs.wsj.com/health/2008/04/07/sen-grassley-knocks-psychiatrists-funding-from-astrazeneca/?mod=WSJBlog&quot;&gt;item&lt;/a&gt;&lt;br /&gt;
- see Grassley&#039;s Physician Payment Sunshine &lt;a href=&quot;http://thomas.loc.gov/cgi-bin/query/z?c110:S.2029:&quot;&gt;bill&lt;/a&gt;
&lt;/p&gt;
&lt;p&gt;
&lt;strong&gt;Related Articles:&lt;br /&gt;
&lt;/strong&gt;AZ takes steps to shore up Seroquel. &lt;a href=&quot;http://www.fiercepharma.com/story/az-takes-steps-to-shore-up-seroquel/2008-02-11&quot;&gt;Report&lt;/a&gt;&lt;br /&gt;
AZ&#039;s Seroquel receives additional approval. &lt;a href=&quot;http://www.fiercebiotech.com/story/az-s-seroquel-receives-additional-approval/2006-10-23&quot;&gt;Report&lt;/a&gt;
&lt;/p&gt;
</description>
 <comments>http://www.fiercepharma.com/story/seroquel-researcher-got-cash-from-az/2008-04-08#comments</comments>
 <category domain="http://www.fiercepharma.com/tags/astrazeneca">AstraZeneca</category>
 <category domain="http://www.fiercepharma.com/tags/charles-grassley">Charles Grassley</category>
 <category domain="http://www.fiercepharma.com/tags/conflict-interest">Conflict of interest</category>
 <category domain="http://www.fiercepharma.com/tags/melissa-delbello">Melissa DelBello</category>
 <category domain="http://www.fiercepharma.com/tags/nih">NIH</category>
 <category domain="http://www.fiercepharma.com/tags/seroquel">Seroquel</category>
 <pubDate>Tue, 08 Apr 2008 06:59:56 -0400</pubDate>
 <dc:creator />
 <guid isPermaLink="false">8810 at http://www.fiercepharma.com</guid>
</item>
</channel>
</rss>
